Blog Archives for category Clinical trials

Phase 2 clinical study for patients with diffuse cutaneous systemic sclerosis (dcSSc) or patients with pulmonary arterial hypertension (PAH)

The American company, Cumberland Pharmaceuticals, is conducting a phase 2 clinical study evaluating the safety and effectiveness of a new… Continue reading »

Press Release – Orphan Drug Designation Granted to Nintedanib for Treatment of Systemic Sclerosis, including Associated Interstitial Lung Disease

Today, Boehringer Ingelheim sent out a press release, announcing that, “… the European Commission (EC) and U.S. Food and Drug Administration… Continue reading »


Efficacy and Safety of Tocilizumab in Participants With Systemic Sclerosis (Clinical trial)

Did you know, that you can look up clinical trials on scleroderma on following sites: and For instance you can find… Continue reading »